tiprankstipranks
Trending News
More News >

Ardent Health price target raised to $18 from $16 at Guggenheim

Guggenheim raised the firm’s price target on Ardent Health (ARDT) to $18 from $16 and keeps a Buy rating on the shares after Ardent reported Q1 EBITDA slightly above consensus. Ardent shares remain “uniquely attractive” in the context of the current policy backdrop, the analyst tells investors.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1